Quercetin

Category
flavonoid
Routes
Oral (PO)
Half-Life (t½)
PO: 11h
Formula
C15H10O7
Molecular Weight
302.24 g/mol
PubChem CID
5280343
Aliases
3,3′,4′,5,7-Pentahydroxyflavone

Pharmacological Mechanism

Flavonol aglycone with mast-cell-stabilising activity (inhibits PLA2 + histamine release), nlrp3 inflammasome inflammasome suppression, and zinc-ionophore activity (shuttles Zn²⁺ across cell membranes, repurposed in early COVID protocols). CD38 inhibitor — preserves cellular nad plus (see niacin nad synthesis) by slowing its CD38-driven hydrolysis. Poorly bioavailable as aglycone; glucoside forms (rutin, isoquercitrin) have better absorption.

Half-Life & Elimination Curve (PO: 11h)

100%50%25%12.5%0%0h0×t½11h1×t½22h2×t½33h3×t½44h4×t½55h5×t½0×t½ (0h): 100% remaining (~0.101 mg/L)1×t½ (11h): 50% remaining (~50.5 µg/L)2×t½ (22h): 25% remaining (~25.2 µg/L)3×t½ (33h): 12.5% remaining (~12.6 µg/L)4×t½ (44h): 6.3% remaining (~6.31 µg/L)5×t½ (55h): 3.1% remaining (~3.16 µg/L)
Plasma (PO)t½ Decay (11h)
  • 0×t½0h100% (0.101 mg/L)
  • 1×t½11h50% (50.5 µg/L)
  • 2×t½22h25% (25.2 µg/L)
  • 3×t½33h12.5% (12.6 µg/L)
  • 4×t½44h6.3% (6.31 µg/L)
  • 5×t½55h3.1% (3.16 µg/L)
Elimination t½11h (PO)
Rate Constant (ke)0.063 h⁻¹
Time to Peak (Tmax)4.74h
Est. Peak (Cmax)0.101 mg/L
Clearance (CL)6.18 L/h
97% Washout (5×t½)55h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Interactions

Chemical Structure & Identifiers

References